Literature DB >> 23605796

Silibinin pretreatment protects against ochratoxin A-mediated apoptosis in primary rat hepatocytes.

E Essid1, E Petzinger.   

Abstract

The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion method yielded hepatocytes, which were stably cultivated without DNA fragmentation for up to 96 h, whereas the collagenase-prepared hepatocytes showed apoptosis events as early as from the start of preparation even in the absence of OTA. Treatment with 12.5 μmol/l OTA of cultured hepatocytes prepared under ETDA perfusion developed DNA-laddering after 24-36 h. Lipopolysaccharide (LPS) of 0.1 up to 12.5 μg/ml showed no apoptotic DNA-effects under these conditions. A low concentration of 26 μmol/l silibinin given prior to OTA slightly prevented OTA-mediated DNA-laddering, whereas a five times higher concentration of silibinin (130 μmol/l) completely inhibited OTA-mediated apoptosis. Under the same conditions, caspase-3 activity in hepatocytes increased in a time-dependent manner under OTA exposure within 12-24 h but was blocked by 130 μmol/l silibinin. In contrast, LPS incubation for 12 and 24 h did not alter caspase-3 activity. To measure viability of OTA-/LPS-treated hepatocytes, the MTT-test and Live/Dead kit were applied. The results demonstrated that the used OTA concentration of 12.5 μmol/l only moderately decreased viability for up to 24 h but showed cytotoxic effects depending on longer incubation times (≥36 h). In contrast, LPS up to 12.5 μg/ml exhibited no cytotoxic effects up to 48 h. In summary, our results showed contrasting effects on apoptosis in primary rat hepatocytes by OTA (produces apoptosis) versus LPS (produces no apoptosis), also depending on the method of hepatocyte preparation. Silibinin at 130 μmol/l showed significant hepatoprotective and antiapoptotic effects against OTA-mediated cell damage on cultured rat hepatocytes.

Entities:  

Year:  2011        PMID: 23605796     DOI: 10.1007/s12550-011-0092-9

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  55 in total

Review 1.  Apoptosis-an introduction.

Authors:  Alfons Lawen
Journal:  Bioessays       Date:  2003-09       Impact factor: 4.345

2.  Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.

Authors:  Christophe Cavin; Thierry Delatour; Maricel Marin-Kuan; Daisy Holzhäuser; Larry Higgins; Claudine Bezençon; Gabriela Guignard; Sylviane Junod; Janique Richoz-Payot; Eric Gremaud; John D Hayes; Sandra Nestler; Peter Mantle; Benoît Schilter
Journal:  Toxicol Sci       Date:  2006-11-16       Impact factor: 4.849

Review 3.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 4.  Toxicokinetics and toxicodynamics of ochratoxin A, an update.

Authors:  Diana Ringot; Abalo Chango; Yves-Jacques Schneider; Yvan Larondelle
Journal:  Chem Biol Interact       Date:  2005-11-15       Impact factor: 5.192

5.  Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin.

Authors:  E Hamada; T Nishida; Y Uchiyama; J Nakamura; K Isahara; H Kazuo; T P Huang; T Momoi; T Ito; H Matsuda
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

6.  Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.

Authors:  A Pfohl-Leszkowicz; M Castegnaro
Journal:  Food Addit Contam       Date:  2005

Review 7.  Ochratoxin A from a toxicological perspective.

Authors:  E Petzinger; K Ziegler
Journal:  J Vet Pharmacol Ther       Date:  2000-04       Impact factor: 1.786

8.  Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor.

Authors:  C Libert; S Van Bladel; P Brouckaert; A Shaw; W Fiers
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1.

Authors:  W Worner; D Schrenk
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

10.  Silibinin protects mice from T cell-dependent liver injury.

Authors:  Jens Schümann; Jennifer Prockl; Alexandra K Kiemer; Angelika M Vollmar; Renate Bang; Gisa Tiegs
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

View more
  4 in total

1.  miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo.

Authors:  Liye Zhu; Tao Yu; Xiaozhe Qi; Bo Yang; Lei Shi; Haoshu Luo; Xiaoyun He; Kunlun Huang; Wentao Xu
Journal:  Toxicol Res (Camb)       Date:  2015-10-08       Impact factor: 3.524

2.  In Silico and In Vitro Studies of Mycotoxins and Their Cocktails; Their Toxicity and Its Mitigation by Silibinin Pre-Treatment.

Authors:  Van Nguyen Tran; Jitka Viktorova; Katerina Augustynkova; Nikola Jelenova; Simona Dobiasova; Katerina Rehorova; Marie Fenclova; Milena Stranska-Zachariasova; Libor Vitek; Jana Hajslova; Tomas Ruml
Journal:  Toxins (Basel)       Date:  2020-02-28       Impact factor: 4.546

3.  Apoptosis induction by OTA and TNF-α in cultured primary rat hepatocytes and prevention by silibinin.

Authors:  Ebtisam Essid; Yousef Dernawi; Ernst Petzinger
Journal:  Toxins (Basel)       Date:  2012-11-02       Impact factor: 4.546

4.  An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage.

Authors:  Zhang-He Goh; Jie Kai Tee; Han Kiat Ho
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.